The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review
Description
Interferon-beta (IFN-β) for Multiple Sclerosis (MS) is turning 30. The COVID-19 pandemic rejuvenated the interest in interferon biology in health and disease, opening translational opportunities beyond neuroinflammation. The antiviral properties of
